Norris Perne & French LLP Novartis Ag Transaction History

Norris Perne & French LLP

  • $1.36 Billion
  • Q3 2024

A detailed history of Norris Perne & French LLP transactions in Novartis Ag stock. As of the latest transaction made, Norris Perne & French LLP holds 2,432 shares of NVS stock, worth $253,608. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,432
Previous 2,432 -0.0%
Holding current value
$253,608
Previous $258,000 8.14%
% of portfolio
0.02%
Previous 0.02%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024
SELL
$92.57 - $107.37 $33,788 - $39,190
-365 Reduced 13.05%
2,432 $258,000
Q1 2024

Apr 16, 2024
SELL
$95.27 - $108.47 $53,922 - $61,394
-566 Reduced 16.83%
2,797 $270,000
Q4 2023

Jan 22, 2024
SELL
$92.27 - $101.54 $922 - $1,015
-10 Reduced 0.3%
3,363 $339,000
Q3 2023

Oct 18, 2023
SELL
$94.73 - $105.13 $47,649 - $52,880
-503 Reduced 12.98%
3,373 $343,000
Q2 2023

Jul 19, 2023
SELL
$92.52 - $104.91 $6,291 - $7,133
-68 Reduced 1.72%
3,876 $391,000
Q1 2023

Apr 20, 2023
BUY
$80.03 - $92.81 $720 - $835
9 Added 0.23%
3,944 $362,000
Q2 2022

Aug 11, 2022
SELL
$80.52 - $93.75 $38,810 - $45,187
-482 Reduced 10.91%
3,935 $333,000
Q1 2022

Apr 26, 2022
SELL
$80.11 - $90.62 $123,129 - $139,282
-1,537 Reduced 25.81%
4,417 $388,000
Q4 2021

Jan 26, 2022
SELL
$79.7 - $88.13 $533,511 - $589,942
-6,694 Reduced 52.93%
5,954 $521,000
Q3 2021

Oct 26, 2021
SELL
$81.78 - $95.14 $10,631 - $12,368
-130 Reduced 1.02%
12,648 $1.03 Million
Q2 2021

Jul 20, 2021
SELL
$85.24 - $94.15 $15.9 Million - $17.6 Million
-186,859 Reduced 93.6%
12,778 $1.17 Million
Q1 2021

Apr 30, 2021
SELL
$83.5 - $98.47 $276,218 - $325,738
-3,308 Reduced 1.63%
199,637 $17.1 Million
Q4 2020

Jan 27, 2021
BUY
$78.07 - $94.43 $2.14 Million - $2.59 Million
27,411 Added 15.62%
202,945 $19.2 Million
Q3 2020

Oct 26, 2020
BUY
$82.14 - $91.0 $312,460 - $346,164
3,804 Added 2.22%
175,534 $15.3 Million
Q2 2020

Jul 23, 2020
BUY
$80.93 - $91.1 $452,236 - $509,066
5,588 Added 3.36%
171,730 $15 Million
Q1 2020

Apr 16, 2020
BUY
$70.67 - $99.01 $2.31 Million - $3.24 Million
32,750 Added 24.55%
166,142 $13.7 Million
Q4 2019

Jan 22, 2020
SELL
$84.35 - $95.37 $51,284 - $57,984
-608 Reduced 0.45%
133,392 $12.6 Million
Q3 2019

Oct 24, 2019
SELL
$85.54 - $94.26 $26,346 - $29,032
-308 Reduced 0.23%
134,000 $11.6 Million
Q2 2019

Jul 19, 2019
SELL
$75.4 - $92.8 $64,014 - $78,787
-849 Reduced 0.63%
134,308 $12.3 Million
Q1 2019

Apr 29, 2019
BUY
$75.32 - $86.15 $236,128 - $270,080
3,135 Added 2.37%
135,157 $13 Million
Q4 2018

Jan 28, 2019
BUY
$73.66 - $82.02 $173,690 - $193,403
2,358 Added 1.82%
132,022 $11.3 Million
Q3 2018

Oct 29, 2018
BUY
$66.94 - $77.43 $343,067 - $396,828
5,125 Added 4.12%
129,664 $11.2 Million
Q2 2018

Jul 24, 2018
BUY
$64.91 - $73.36 $175,906 - $198,805
2,710 Added 2.22%
124,539 $9.41 Million
Q1 2018

Apr 17, 2018
BUY
$70.39 - $84.15 $25,903 - $30,967
368 Added 0.3%
121,829 $9.85 Million
Q4 2017

Jan 23, 2018
BUY
$72.33 - $77.64 $21,843 - $23,447
302 Added 0.25%
121,461 $10.2 Million
Q3 2017

Nov 01, 2017
BUY
$74.14 - $77.27 $8.98 Million - $9.36 Million
121,159
121,159 $10.4 Million

Others Institutions Holding NVS

# of Institutions
1,435
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Norris Perne & French LLP Portfolio

Follow Norris Perne & French LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norris Perne & French LLP, based on Form 13F filings with the SEC.

News

Stay updated on Norris Perne & French LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email